PPT-SARS-CoV-2 and COVID-19 David H. Spach, MD
Author : rosemary | Published Date : 2021-12-06
Professor of Medicine Division of Infectious Diseases University of Washington Last Updated December 7 2020 Gretchen Snoeyenbos Newman MD Senior Fellow Division
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "SARS-CoV-2 and COVID-19 David H. Spach, ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
SARS-CoV-2 and COVID-19 David H. Spach, MD: Transcript
Professor of Medicine Division of Infectious Diseases University of Washington Last Updated December 7 2020 Gretchen Snoeyenbos Newman MD Senior Fellow Division of Infectious Diseases University of Washington. Page 9
Yan Leyfman
1
, Timothy K. Erick
1
, Pushpa Sharma
1,2
1
WACEM-ACAIM Joint Global COVID-19 Taskforce Immunology Division, USA
2
Department of Anaesthesiology, Uniformed Services Universit One Health Partners Monthly COVID-19 WebinarCoordinated by the CDCOne Health Office in partnership with the One Health Federal Interagency COVID-19 Coordination OH-FICC GroupOne SARS-CoV-Updated 3/2/2020Samuel R Dominguez MD PhD and Ann-Christine Nyquist MD MSPH1What is the SARS-CoV-2and where did it come fromSARS-CoV-2 previously called 2019 novel coronavirusis a coronavirus The more the virus circulates, the more the virus will evolve
Most changes have little to no impact on the virus’s properties or behaviour
However, some changes to SARS-CoV-2 lead to the emergence of variants that may affect: Analytical & Clinical Performance Data (OUS). June 2020. HOOD05162003091712. FTD SARS-CoV-2 Assay*. Instructions for Use. *. CE-IVD labelled for diagnostic use in the EU. . The . Instructions for Use . An Initiative of DBT-AIs. Coordinated by . National Institute of Biomedical Genomics (NIBMG), . Kalyani. . P. articipating Institutes:. Teams:. . . NIBMG:. . Arindam. . Maitra. , . Nidhan. Biswas, . 2019). PRESENTED BY. Image: . “Coronaviruses viewed under an electron microscope. Note the characteristic crown-like (corona) appearance” . By CDC/Dr. Fred Murphy. ETIOLOGY. Coronaviruses (. CoV. Webinar presenters:. Robert Davenport, MD University of Michigan . (rddvnprt@med.umich.edu). Alesia Kaplan, MD University of Pittsburgh . (akaplan@itxm.org). Hua Shan, MD Stanford University . (hshan@stanford.edu). A drug repurposing approach for COVID-19. Md. Riad Chowdhury. 1. , . Md. . Adnan. 2,*. , . Md. Nazim Uddin . Chy. 1,*. , . A.T.M. Mostafa Kamal. 1. 1. Department of Pharmacy, International Islamic University Chittagong, . भारतीय आयुविान अनुसंधान पररषद
वा्य अनुसंधान ववभाग
,
-
CoV
-
2
Patricia Slev, PhD, D(ABCC)
Section Chief, Immunology, ARUP Laboratories
Associate Professor, University of Utah School of Medicine
patricia.slev@aruplab.com
1
DISCLOSURES
P
Slev
None
OBJEC . alberto.tommasini@burlo.trieste.it. Trieste, 24 NOVEMBRE 2021. SARS-CoV-2. Enveloped, with a . ssRNA. genome. 4 Coronavirus genera. Alphacoronavirus. (Mammals). 229E and NL63. Betacoronavirus. (Mammals). Department Medicine. UF College of Medicine. Randomized trial of bicalutamide to block . TMPRSS2 in males with COVID-19 infection. UF-CTSI Pilot grant project. Association between . Cancer and COVID-19 Biology. Virupaksha. A. Bastikar. 1. ; . Pramodkumar. Gupta. 2. ; Alpana V. Bastikar. 3. and Santosh S. Chhajed. 4. 1. Amity Institute of Biotechnology, Amity University, Mumbai, Maharashtra;. 2. School of Biotechnology and Bioinformatics, D. Y. .
Download Document
Here is the link to download the presentation.
"SARS-CoV-2 and COVID-19 David H. Spach, MD"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents